Clinical Trial Update: Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing genetic factors influencing response to fesoterodine in elderly patients with urge urinary incontinence has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urge Urinary Incontinence

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Urge Urinary Incontinence | Phase 3 | Status: COMPLETED | Results posted: 2018-10-22